Abstract:TN THE NATIONAL Health Service nearly 100 per cent of the population are on doctors' lists. In favourable circumstances this could provide the opportunity to study records of families and to extract information in relation to heritable morbidity. The family doctor in the National Health Service has thus got an unparalleled opportunity for family studies, provided of course, he has been keeping records and provided he has not a too rapidly changing practice population. In our group practice partnership, comprising about 18,000 patients, we have a good opportunity to study the possibility of collating eugenically relevant information in families. It is perhaps appropriate here to describe the type of practice we are working in. There are six principals and a recently appointed assistant. The district is a semi-industrial re-housing area in Edinburgh which has gradually extended during the past twenty years. There is a predominance f occupations in Registrar General Social Class and v, with a fair number of iii and a few in ii. e housing consists mainly of tenements altthough there is a large area of prefabricated ouses, single family houses, along with some semi-detached villa type of buildings. There are fcw owners of their own houses, nearly ninety per cent being rented from the local authority. The kcommunity is religiously of a mixed nature, with a slight preponderance of non-catholics. We So nduct our practices in the main from two specially adapted buildings with nursing and secretarial staff available, and close co-operation with health visitors and the social services. The National Health Service records by themselves are not very-helpful, as there is no ready way of obtaining the information on a quantitative basis about any one condition, without going through all the records. If the information extracted from a National Health Service Practice is to be of any use, it would have to be based on a sufficiently large number of patients. To obtain data on this scale from the existing records would require repeated "going through" the National Health Service records which is a practical impossibility. In 1958 we began to plan an investigation to explore the possibilities of family doctor records in the National Health Service. A pilot survey of the patients with letter "A" showed that we would have a monumental task if we decided to extract all the information already recorded. What was required was a recording system of coded information allowing ready access to relevant information for the conduct of further, and particularly long term studies. Very early on we realized that in this group practice it would be impossible to code and index all morbidity met with in our daily work. We decided to limit ourselves to the clinical conditions which produce a pathology with permanent changes, viz. mainly all chronic conditions, congenital abnormalities. Another objective was to demonstrate that such a system of recording, coding and indexing could be used

First measurement of unpolarized semi-inclusive deep-inelastic scattering cross sections from a 3 He target

Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes

Inactivation of Latent HIV-1 Proviral DNA Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Treatment and the Assessment of Off-Target Effects.

Systemic Administration of Combinatorial Dsirnas Via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice

Family follow-up studies into the eugenic aspects of morbidity: Interim progress report.

HIV-1 Inhibition in Cells with CXCR4 Mutant Genome Created by CRISPR-Cas9 and Piggybac Recombinant Technologies.

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Highly potent and broadly neutralizing anti-CD4 trimeric nanobodies inhibit HIV-1 infection by inducing CD4 conformational alteration

Genome Modification of CXCR4 by Staphylococcus Aureus Cas9 Renders Cells Resistance to HIV-1 Infection.

CCR5 Editing by Staphylococcus Aureus Cas9 in Human Primary CD4+ T Cells and Hematopoietic Stem/progenitor Cells Promotes HIV-1 Resistance and CD4+ T Cell Enrichment in Humanized Mice

A Novel CXCR4 Targeting Protein SDF-1/54 As an HIV-1 Entry Inhibitor.

Genome Scale Screening Identification of SaCas9/gRNAs for Targeting HIV-1 Provirus and Suppression of HIV-1 Infection

Noncompliance May Render Migraine Prophylaxis Useless, But Once-Daily Regimens Are Better

[Non calculous ureteral obstruction and Crohn's disease].

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9

Glycolipids as the major autoantigens of cytoplasmatic islet cell antibodies.

Lentiviral Delivery of RNAi Effectors Against HIV-1

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41

pH-sensitive dual-preventive siRNA-based nanomicrobicide reactivates autophagy and inhibits HIV infection in vaginal CD4+ cells

Tandem Bispecific Neutralizing Antibody Eliminates HIV-1 Infection in Humanized Mice

Down-regulation of CXCR4 Expression in MT4 Cells by a Recombinant Vector Expressing Antisense RNA to CXCR4 and Its Potential Anti-Hiv-1 Effect.